Blood-based tests show potential for early Alzheimer’s detection | Healthcare Asia Magazine
, APAC
Photo from Envato

Blood-based tests show potential for early Alzheimer’s detection

More than 150 in vitro diagnostic tests are currently in development.

Blood-based tests are emerging as potential tools for the early detection of Alzheimer’s disease, offering a less invasive alternative to traditional methods like PET scans and cerebrospinal fluid analysis, said GlobalData.

The report revealed that the disease has reached over 55 million people globally, with numbers projected to triple by 2050.

Moreover, more than 150 in vitro diagnostic tests for Alzheimer’s disease are in development, many of which aim to fill gaps in early detection.

“For Alzheimer’s disease, reliable and accessible testing could lead to earlier detection, giving patients more time to pursue interventions and lifestyle changes,” said Ashley Clarke, Senior Medical Analyst at GlobalData.

At least five devices in the pipeline are currently undergoing regulatory approval in the US and Europe. However, the development of these tests faces ethical and regulatory challenges.

These concerns include the potential for overdiagnosis, exposure to sensitive health data, and the implications for insurance premiums.

“Predictive testing also introduces ethical considerations around informed consent and potential psychological impacts for patients learning their risks in a disease still lacking a cure,” the report said.

Follow the link s for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

NUHCS to start using breakthrough drug for rare lung condition
Winrevair, which treats hypertension from constricted lung arteries, costs  $3,700-$6,730
Healthcare
Singapore’s aged care homes fall short
Their services are routinary and not personalised mainly due to resource constraints.
Healthcare
Electronic health records with AI show promise
They are also at risk from backdoor attacks, data poisoning and unauthorised access.